{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T10:58:25Z","timestamp":1725706705688},"publisher-location":"Boston, MA","reference-count":30,"publisher":"Springer US","isbn-type":[{"type":"print","value":"9781468486186"},{"type":"electronic","value":"9781468486162"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1984]]},"DOI":"10.1007\/978-1-4684-8616-2_35","type":"book-chapter","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T16:34:05Z","timestamp":1353602045000},"page":"359-368","source":"Crossref","is-referenced-by-count":0,"title":["Vasodilator Treatment of Primary Pulmonary Hypertension"],"prefix":"10.1007","author":[{"given":"L.","family":"Cotter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"35_CR1","series-title":"World Health Organization","volume-title":"Primary pulmonary hypertension report on a WHO meeting","author":"S Hatano","year":"1975","unstructured":"S. Hatano, T. Strasser, Primary pulmonary hypertension report on a WHO meeting. World Health Organization. (1975)."},{"key":"35_CR2","series-title":"Prog. Card.","volume-title":"Primary pulmonary hypertension","author":"RP Gatewood","year":"1979","unstructured":"R.P. Gatewood, P.N. Yu, Primary pulmonary hypertension. Prog. Card. (1979)."},{"key":"35_CR3","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1136\/hrt.41.6.702","volume":"41","author":"L Suarez","year":"1979","unstructured":"L. Suarez, Long-term follow-up in primary pulmonary hypertension. Br. Heart J. 41: 702 (1979).","journal-title":"Br. Heart J."},{"key":"35_CR4","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1136\/hrt.38.3.264","volume":"38","author":"PDV Bourdillon","year":"1976","unstructured":"P.D.V. Bourdillon, C.M. Oakley, Regression of primary pulmonary hypertension. Br. Heart J. 38: 264 (1976).","journal-title":"Br. Heart J."},{"key":"35_CR5","first-page":"557","volume":"21","author":"P Wood","year":"1959","unstructured":"P. Wood, Pulmonary hypertension with special reference to the vasoconstrictive factor. Br. Heart J. 21: 557 (1959).","journal-title":"Br. Heart J."},{"key":"35_CR6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/qjmed\/os-21.81.51","volume":"21","author":"RC Clarke","year":"1927","unstructured":"R.C. Clarke, C.F. Coombs, G. Hadfield, A.T. Todd, On certain abnormalities congenital and aquired of the pulmonary arteries. Q. J. Med. 21: 51 (1927).","journal-title":"Q. J. Med."},{"key":"35_CR7","volume-title":"Pathology of pulmonary hypertension","author":"CA Wangevoort","year":"1977","unstructured":"C.A. Wangevoort, N. Wangevoort, Pathology of pulmonary hypertension. New York, John Willey and Sons, (1977)."},{"key":"35_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/thx.26.3.262","volume":"26","author":"JM Kay","year":"1971","unstructured":"J.M. Kay, P. Smith, D. Heath, Aminorex and the pulmonary circulation. Thorax 26: 262 (1971).","journal-title":"Thorax"},{"key":"35_CR9","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1136\/hrt.35.8.824","volume":"35","author":"M Fahlen","year":"1973","unstructured":"M. Fahlen, H. Bergman, Phenformin and pulmonary hypertension. Br. Heart J. 35: 82 (1973).","journal-title":"Br. Heart J."},{"key":"35_CR10","first-page":"141","volume":"94","author":"BJ Sproule","year":"1966","unstructured":"B.J. Sproule, E.A. Phillipson, C.M. Couves, R.T. Brownlee, Acute pulmonary hypertension in idiopathic lactic acidosis. Canadian Medical Association Journal 94: 141 (1966).","journal-title":"Canadian Medical Association Journal"},{"key":"35_CR11","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1136\/thx.35.4.269","volume":"35","author":"M Honey","year":"1980","unstructured":"M. Honey, L. Cotter, N. Davies, D. Denison, Clinical and haemodynamic effects of diazoxide in primary pulmonary hypertension. Thorax 35: 269 (1980).","journal-title":"Thorax"},{"key":"35_CR12","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1056\/NEJM197606032942306","volume":"294","author":"J Koch-Weser","year":"1976","unstructured":"J. Koch-Weser, Drug therapy: diazoxide. N. Engl. J. Med. 294: 1271 (1976).","journal-title":"N. Engl. J. Med."},{"key":"35_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/0002-8703(74)90428-1","volume":"87","author":"M Moser","year":"1974","unstructured":"M. Moser, Diazoxide: an effective vasodilator in accelerated hypertension. Am. Heart J. 87: 791 (1974).","journal-title":"Am. Heart J."},{"key":"35_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0034-5687(79)90029-X","volume":"36","author":"NJH Davies","year":"1979","unstructured":"N.J.H. Davies, D.M. Denison, The measurement of metabolic gas exchange by mass spectrometry alone. Respir. Physiol. 36: 261 (1979).","journal-title":"Respir. Physiol."},{"key":"35_CR15","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/0002-9343(51)90020-4","volume":"11","author":"DT Dresdale","year":"1951","unstructured":"D.T. Dresdale, M. Schultz, R.J. Michton, Primary pulmonary hypertension. Am. J. Med. 11: 686 (1951).","journal-title":"Am. J. Med."},{"key":"35_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0002-8703(61)90510-5","volume":"61","author":"RF Grover","year":"1961","unstructured":"R.F. Grover, J. Reeves, S.G. Blount, Tolazoline hydrochloride: an effective pulmonary vasodilator. Am. Heart J. 61:5 (1961).","journal-title":"Am. Heart J."},{"key":"35_CR17","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1056\/NEJM197612162952506","volume":"295","author":"U Shettigar","year":"1976","unstructured":"U. Shettigar, H.N. Hultgren, M. Speatr, R. Martin, H.D. Davies, Primary pulmonary hypertension: favorable effect of isoproterenol. N. Engl. J. Med. 295: 1414 (1976).","journal-title":"N. Engl. J. Med."},{"key":"35_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0140-6736(60)91854-7","volume":"1","author":"DEL Wilckin","year":"1960","unstructured":"D.E.L. Wilckin, K.M. MacKenzie, J.F. Goodwin, Anticoagulation therapy of obliterative pulmonary hypertension. Lancet 1: 781 (1960).","journal-title":"Lancet"},{"key":"35_CR19","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1093\/cvr\/12.12.752","volume":"12","author":"F Rengo","year":"1978","unstructured":"F. Rengo, B. Trimarco, M. Chiarello, Histamine and hypoxic pulmonary hypertension: a quantitative study. Cardiovasc. Res. 12: 752 (1978).","journal-title":"Cardiovasc. Res."},{"key":"35_CR20","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1136\/hrt.40.12.1397","volume":"40","author":"J Szczeklik","year":"1978","unstructured":"J. Szczeklik, Effects of prostaglandin El on the pulmonary circulation in patients with pulmonary hypertension. Br. Heart J. 40: 1397 (1978).","journal-title":"Br. Heart J."},{"key":"35_CR21","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0002-9149(78)90102-9","volume":"42","author":"FS Daoud","year":"1978","unstructured":"F.S. Daoud, J.T. Reeves, D.B. Kelly, Isoproterenol as a potential pulmonary vasodilator in primary pulmonary hypertension. Am. J. Cardiol. 42: 817 (1978).","journal-title":"Am. J. Cardiol."},{"key":"35_CR22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.7326\/0003-4819-90-5-772","volume":"90","author":"JN Ruskin","year":"1979","unstructured":"J.N. Ruskin, A.M. Hutter, Primary pulmonary hypertension treated with phentolamine. Ann. Intern. Med. 90: 772 (1979).","journal-title":"Ann. Intern. Med."},{"key":"35_CR23","first-page":"1177","volume":"3","author":"U Elkayam","year":"1978","unstructured":"U. Elkayam, W. Frishman, C. Yoran, J. Strom, M. Cohen, Unfavourable haemodynamic and clinical effects of isoproterenol therapy in primary pulmonary hypertension. Card. Med. 3: 1177 (1978).","journal-title":"Card. Med."},{"key":"35_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1056\/NEJM198001103020201","volume":"302","author":"RJ Rubin","year":"1980","unstructured":"R.J. Rubin, H.R. Peter, Oral Hydrallazine therapy for primary pulmonary hypertension. N. Engl. J. Med. 302: 69 (1980).","journal-title":"N. Engl. J. Med."},{"key":"35_CR25","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1136\/hrt.44.3.352","volume":"44","author":"F Camerini","year":"1980","unstructured":"F. Camerini, E. Alberti, S. Klugman, A. Salvi, Primary pulmonary hypertension: effects of Nifedipine. Br. Heart J. 44: 352 (1980).","journal-title":"Br. Heart J."},{"key":"35_CR26","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1136\/hrt.40.5.572","volume":"40","author":"SWS Wang","year":"1978","unstructured":"S.W.S. Wang, J.E.F. Pohl, D.J. Rowlands, E.G. Wade, Diazoxide in treatment of primary pulmonary hypertension. Br. Heart J. 40: 572 (1978).","journal-title":"Br. Heart J."},{"key":"35_CR27","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1056\/NEJM198001103020204","volume":"302","author":"WP Klinke","year":"1980","unstructured":"W.P. Klinke, J.A.L. Gilbert, Diazoxide in primary pulmonary hypertension. N. Engl. J. Med. 302: 91 (1980).","journal-title":"N. Engl. J. Med."},{"key":"35_CR28","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1136\/bmj.4.5780.142","volume":"1","author":"JEF Pohl","year":"1971","unstructured":"J.E.F. Pohl, B. Thurstan, Use of diazoxide in hypertension with renal failure. Br. Med. J. 1: 142 (1971).","journal-title":"Br. Med. J."},{"key":"35_CR29","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1056\/NEJM198005293022213","volume":"302","author":"S Rich","year":"1980","unstructured":"S. Rich, Vasodilator therapy for pulmonary hypertension (letter) N. Engl. J. Med. 302: 1260 (1980).","journal-title":"N. Engl. J. Med."},{"key":"35_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1056\/NEJM198001103020210","volume":"302","author":"JT Reeves","year":"1980","unstructured":"J.T. Reeves, Hope in primary pulmonary hypertension. N. Engl. J. Med. 302: 81 (1980).","journal-title":"N. Engl. J. Med."}],"container-title":["Advances in Experimental Medicine and Biology","Thrombosis and Cardiovascular Disease"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4684-8616-2_35.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T20:48:04Z","timestamp":1619902084000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4684-8616-2_35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1984]]},"ISBN":["9781468486186","9781468486162"],"references-count":30,"URL":"https:\/\/doi.org\/10.1007\/978-1-4684-8616-2_35","relation":{},"ISSN":["0065-2598"],"issn-type":[{"type":"print","value":"0065-2598"}],"subject":[],"published":{"date-parts":[[1984]]}}}